Sotirios G. Stergiopoulos
Founder bei A2a Pharmaceuticals, Inc.
Profil
Sotirios G.
Stergiopoulos is the founder of A2a Pharmaceuticals, Inc. (founded in 2016) and currently holds the position of President, Chief Executive Officer & Director.
He is also currently working as a Director at Ricovr Healthcare, Inc. In his former positions, Dr. Stergiopoulos worked as an Executive Director-US Medical Affairs Oncology at Celgene Corp.
from 2014 to 2016.
He also served as Deputy Director-Global Medical Affairs Oncology at Bayer Healthcare LLC from 2009 to 2012 and as Senior Director-Global Brand Medical at Novartis AG from 2012 to 2014.
Additionally, he held the position of Vice President & Head-Global Medical Affairs at Shire Plc and Baxalta, Inc. in 2016.
From 2017 to 2019, he worked as the Chief Medical Officer & Senior Vice President at Ipsen SA and Ipsen Pharmaceuticals, Inc.Dr. Stergiopoulos completed his undergraduate studies at Stony Brook University.
He then pursued graduate studies at The Johns Hopkins University.
He also holds a doctorate degree from Poznan University of Medical Science.
Aktive Positionen von Sotirios G. Stergiopoulos
| Unternehmen | Position | Beginn |
|---|---|---|
A2a Pharmaceuticals, Inc.
 A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services A2a Pharmaceuticals, Inc. develops proprietary computational systems and new therapeutics that serve highly unmet patient needs. The company was founded by Edward Painetr, Sridhar Wempati, Brendan Kelly, and Matthew Welsch and is headquartered in New York, NY. | Founder | 01.01.2016 |
Ricovr Healthcare, Inc.
 Ricovr Healthcare, Inc. Medical SpecialtiesHealth Technology Ricovr Healthcare, Inc. engages in patent-pending technology to manufacture and commercialize point-of-care medical devices for diverse markets. The company was founded by Himanshu Bhatia and Piyush Sadana and is headquartered in Princeton NJ. | Director/Board Member | - |
Ehemalige bekannte Positionen von Sotirios G. Stergiopoulos
| Unternehmen | Position | Ende |
|---|---|---|
| IPSEN | Chief Tech/Sci/R&D Officer | 01.06.2019 |
Ipsen Pharmaceuticals, Inc.
 Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ipsen Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Morristown, NJ. | Chief Tech/Sci/R&D Officer | 01.06.2019 |
| BAXALTA INC | Corporate Officer/Principal | 01.10.2016 |
| SHIRE | Corporate Officer/Principal | 01.10.2016 |
| CELGENE | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Sotirios G. Stergiopoulos
| Stony Brook University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| Poznan University of Medical Science | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IPSEN | Health Technology |
| NOVARTIS AG | Health Technology |
| BIOMEA FUSION, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Bayer Healthcare LLC
 Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Ipsen Pharmaceuticals, Inc.
Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ipsen Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Morristown, NJ. | Health Technology |
A2a Pharmaceuticals, Inc.
A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services A2a Pharmaceuticals, Inc. develops proprietary computational systems and new therapeutics that serve highly unmet patient needs. The company was founded by Edward Painetr, Sridhar Wempati, Brendan Kelly, and Matthew Welsch and is headquartered in New York, NY. | Technology Services |
Ricovr Healthcare, Inc.
Ricovr Healthcare, Inc. Medical SpecialtiesHealth Technology Ricovr Healthcare, Inc. engages in patent-pending technology to manufacture and commercialize point-of-care medical devices for diverse markets. The company was founded by Himanshu Bhatia and Piyush Sadana and is headquartered in Princeton NJ. | Health Technology |
